Silexion Therapeutics Corp (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

1.670

+0.020 (1.21%)

Feb 11, 2026, 4:00 PM EST - Market closed

Silexion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2013	FY 2012
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Market Capitalization	5	3	42	-	-
Market Cap Growth	461.58%	-92.33%	-	-	-
Enterprise Value	-2	6	41	-	-
Last Close Price	1.65	30.15	1464.75	-	-
PB Ratio	0.74	-0.81	13.99	-	-
Debt / Equity Ratio	0.29	-1.13	0.06	-	-
Net Debt / Equity Ratio	-1.03	-0.83	-1.47	-1.13	-0.98
Net Debt / EBITDA Ratio	0.79	-0.26	0.95	0.58	1.68
Net Debt / FCF Ratio	0.67	-0.39	0.97	0.99	1.75
Quick Ratio	3.32	0.34	2.09	3.64	10.47
Current Ratio	3.97	0.64	2.27	3.85	10.64
Return on Equity (ROE)	-771.23%	-	-	-116.66%	-
Return on Assets (ROA)	-77.60%	-193.54%	-	-62.13%	-
Return on Capital Employed (ROCE)	-103.40%	1904.70%	-153.00%	-195.10%	-58.60%
Earnings Yield	-179.24%	-510.30%	-11.77%	-	-
FCF Yield	-208.10%	-261.25%	-10.81%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q